Found 8 matching trials
A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients NA Acute myeloid leukemia (AML) is one of the most common hematologic malignan...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Lisaftoclax Plus Azacitidine Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients at High Risk of Relapse PHASE3 This study evaluates the efficacy and safety of maintenance therapy with li...
Show More Location
Multiple Locations
Learn More & Join Trial
A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia PHASE3 A global, multicenter, randomized, double-blind, placebo-controlled, phase ...
Show More Location
Hematology Hospital of the Chinese Academy of Medical Sciences
Learn More & Join Trial
Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4). PHASE3 A global multicenter, randomized, double-blind, placebo-controlled, pivotal...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML PHASE1 The purpose of this study is to assess the safety, pharmacokinetic profile ...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia NA To study the optimal therapeutic strategies for salvage treatment of refrac...
Show More Learn More & Join Trial
Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy PHASE2 This is a phase II/III, multicenter, randomized, three-arm, open-label, par...
Show More Status
Enrolling By Invitation
Location
The First Affiliated Hospital of Zhejiang University
Learn More & Join Trial
Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy PHASE2 This is a phase II/III, multicenter, randomized, three-arm, open-label, par...
Show More Status
Enrolling By Invitation
Location
The First Affiliated Hospital of Zhejiang University
Learn More & Join Trial